SimLiminal
Lead Participant:
CGA SIMULATION LIMITED
Abstract
Public description
Around 75 million inhalers are prescribed every year in the UK for the treatment of respiratory diseases like asthma, of which 70% are pressurised metered-dose inhalers (pMDIs) made with single use plastic (polypropylene) 'actuators'. Research shows most used inhalers are disposed of at home, ending up in landfill or low-temperature incineration, despite initiatives to encourage recycling.
We are seeking to fundamentally re-design these life-saving devices so that the use of plastic is minimised or eliminated.
Our vision is to inspire other industry-led initiatives to design out persistent plastic wastes in the healthcare sector through re-imagining how healthcare equipment can be designed for reuse and valued by users. Human-centred design can be used to support a more sustainable NHS, while generating jobs in the UK green economy.
Around 75 million inhalers are prescribed every year in the UK for the treatment of respiratory diseases like asthma, of which 70% are pressurised metered-dose inhalers (pMDIs) made with single use plastic (polypropylene) 'actuators'. Research shows most used inhalers are disposed of at home, ending up in landfill or low-temperature incineration, despite initiatives to encourage recycling.
We are seeking to fundamentally re-design these life-saving devices so that the use of plastic is minimised or eliminated.
Our vision is to inspire other industry-led initiatives to design out persistent plastic wastes in the healthcare sector through re-imagining how healthcare equipment can be designed for reuse and valued by users. Human-centred design can be used to support a more sustainable NHS, while generating jobs in the UK green economy.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| CGA SIMULATION LIMITED | £74,983 | £ 74,983 |
Participant |
||
| INNOVATE UK |
People |
ORCID iD |
| Jonathan Wetherall (Project Manager) |